Rubio, Terrence L.
HRN: 21-84-25 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/25/2022
CEFTRIAXONE 1G (VIAL)
08/25/2022
09/01/2022
IVTT
860mg
OD
ATP; PCAP
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaEye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes